Search for: "Cephalon Inc."
Results 81 - 100
of 151
Sorted by Relevance
|
Sort by Date
15 Jan 2009, 6:39 pm
While Zyprexa has been subject of lawsuits, other drug makers such as Cephalon Inc. [read post]
10 Feb 2010, 4:47 pm
- UK: EWCA dismisses Human Genome Sciences appeal against decision finding invalidity; invention not ‘susceptible of industrial application’: Eli Lilly v Human Genome Sciences Inc (EPLAW) (IPKat) Nuvigil (Armodafinil) – US: Patent infringement complaints filed in Colorado and Delaware following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Cephalon's Nuvigil: Cephalon, Inc. et al.… [read post]
27 Jun 2011, 2:18 am
Court of Appeal (Criminal Division) Manchester Police, R (On the Application Of) v Hookway & Anor [2011] EWHC 1578 (Admin) (19 May 2011) Attorney General v Fraill & Anor [2011] EWCA Crim 1570 (16 June 2011) Court of Appeal (Civil Division) Zinda v Bank of Scotland Plc [2011] EWCA Civ 706 (23 June 2011) High Court (Chancery Division) Chemistree Homecare Ltd & Ors v Roche Products Ltd [2011] EWHC 1579 (Ch) (16 June 2011) Cowderoy v Cranfield [2011] EWHC 1616 (Ch) (24 June 2011) High… [read post]
28 May 2015, 9:30 pm
Cephalon, Inc. settled with the Federal Trade Commission (FTC) for allegedly reducing competition by preventing the sale of generic versions of the sleep-disorder drug, Provigil. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
22 Oct 2009, 4:23 am
Cephalon, Inc., 2009 WL 3245485 (D.N.J. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
16 Oct 2008, 3:27 pm
Cephalon Inc., No. 07-2702 (3rd Cir. [read post]
18 Aug 2010, 12:19 am
Eon Labs, Inc. [read post]
19 Mar 2016, 10:13 am
Cephalon, Inc. v. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) (Patent Quality Review Blog) Nuvigil (Armodafinil) – US: Patent infringement complaint filed following a Para IV certification: Cephalon, Inc. et al. v. [read post]
13 Jan 2014, 4:02 am
Take for example, the pharmaceuticals case of Cephalon Inc v Orchid Europe Ltd [2010] EWHC 2945 (Pat) [briefly noted on PatLit here] in which Floyd J (as he was) treated the issue of who is likely to suffer the most irreparable harm as the key factor in the balance of convenience assessment itself: "Balance of convenienceThere is no dispute as to the approach which I should apply. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
30 Nov 2017, 8:59 pm
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
29 Jul 2013, 12:16 pm
Cephalon Inc. et al. v. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
20 Mar 2014, 7:48 am
Cephalon, Inc. v. [read post]
10 Jul 2013, 12:00 am
While synthesizing and screening compounds is considered routine experimentation, the Court noted in Cephalon, Inc. v. [read post]
10 Oct 2007, 9:15 pm
Manufactured by Cephalon, Inc., Fentora is most commonly prescribed to treat breakthrough pain in terminal cancer patients who have already developed a tolerance to opioid pain medications. [read post]
